| Literature DB >> 11937356 |
Seiichiro Ogawa1, Yuko Kobayashi Matsunaga, Yoshiyuki Suzuki.
Abstract
N-Octyl-beta-valienemine (1), a potent beta-glucocerebrosidase inhibitor, was chemically transformed into two biologically interesting compounds: the 4-epimer, beta-galacto-type N-octyl-valienamine, and the 4-O-(beta-D-galactopyranosyl) derivative, a carba-lactosylceramide analogue. The former, interestingly, could be demonstrated to act as a very effective inhibitor (IC(50)=0.3 microM) of human beta-galactosidase. The latter exhibited moderate inhibitory activity (IC(50)=20 microM) against beta-glucocerebrosidase (mouse liver).Entities:
Mesh:
Substances:
Year: 2002 PMID: 11937356 DOI: 10.1016/s0968-0896(02)00005-6
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641